Trenbolone Acetate
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C20H24O3 ▲312.41▲(CN 1-Aug-2023)
Estra-4,9,11-trien-3-one, 17-(acetyloxy)-, (17β)-;
▲(17β)-3-Oxoestra-4,9,11-trien-17-yl acetate ▲(CN 1-Aug-2023) CAS RN®: 10161-34-9; UNII: RUD5Y4SV0S..
1 DEFINITION
Trenbolone Acetate contains NLT 97.0% and NMT 103.0% of C20H24O3, calculated on the dried basis.
2 IDENTIFICATION
A. SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 197K
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
PROCEDURE
Diluent: Acetonitrile, methanol, water, and acetic acid (36.5:30:33.5:0.1)
Solution A: Acetonitrile, methanol, and water (36.5:30:33.5)
Solution B: Acetonitrile and methanol (9:1)
Mobile phase: See the gradient table below.
| Time (min) | Solution A (%) | Solution B (%) |
| 0 | 100 | 0 |
| 6 | 100 | 0 |
| 16 | 0 | 100 |
| 26 | 0 | 100 |
| 26.1 | 100 | 0 |
| 30 | 100 | 0 |
Standard solution: 1 mg/mL of USP Trenbolone Acetate RS in Diluent. Sonicate, if necessary, to dissolve.
Sample solution: 1 mg/mL of Trenbolone Acetate in Diluent. Sonicate, if necessary, to dissolve.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 229 nm
Column: 4.6-mm x 10-cm; 3-µm packing L1
Flow rate: 1.0 mL/min
Injection size: 5 µL
System suitability
Samples: Standard solution
Suitability requirements
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of C20H24O3, in the portion of Trenbolone Acetate taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of Trenbolone Acetate from the Sample solution Tu
rS = peak response of trenbolone acetate from the Standard solution S
CS = concentration of USP Trenbolone Acetate RS in the Standard solution (mg/mL) s
CU = concentration of Trenbolone Acetate in the Sample solution (mg/mL)
Acceptance criteria: 97.0%-103.0%, on the dried basis
4 IMPURITIES
4.1 INORGANIC IMPURITIES
RESIDUE ON IGNITION (281): NMT 0.1%
Change to read:
4.2 ORGANIC IMPURITIES
PROCEDURE
Diluent, Solution A, Solution B, Mobile phase, Standard solution, Sample solution and Chromatographic system: Proceed as directed in the Assay.
System suitability solution: 1 mg/mL of USP Trenbolone Acetate System Suitability Mixture RS in Diluent. Sonicate, if necessary, to dissolve.
System suitability
Samples: Standard solution and System suitability solution
[NOTE-The relative retention times for ▲11,12-dihydrotrenbolone acetate ▲(CN 1-Aug-2023) and trenbolone acetate are 1.2 and 1.0, respectively.]
Suitability requirements
Resolution: NLT 3.0 between trenbolone acetate and ▲11,12-dihydrotrenbolone acetate ▲(CN 1-Aug-2023), System suitability solution
Column efficiency: NLT 8000 theoretical plates for the trenbolone acetate peak, System suitability solution
Relative standard deviation: NMT 2.0%, Standard solution
Analysis
Sample: Sample solution
Calculate the percentage of each impurity in the portion of Trenbolone Acetate taken:
Result = (100 x rU)/[(rS + S) × F]
rU = peak response of each impurity from the Sample solution
rS = peak response of Trenbolone Acetate from Sample solution.
S = sum of the peak responses of each impurity, each divided by their respective response factor
F = relative response factor (see Impurity Table 1)
Acceptance criteria
Individual impurities: See Impurity Table 1.
Total specified and unspecified impurities: NMT 2.0%
Reporting level for impurities: NMT 0.10%
Impurity Table 1
| Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
| ▲Trenbolonea ▲(CN 1-Aug-2023) | 0.4 | 1.04 | 1.0 |
| ▲α -Trenbolone acetateb ▲(CN 1-Aug-2023) | 0.8 | 1.10 | 0.5 |
| Trenbolone acetate | 1.0 | — | — |
| ▲11,12-Dihydrotrenbolone acetatec ▲(CN 1-Aug-2023) | 1.2 | 1.0 | ▲1.0▲ (RB 1-Aug-2023) |
| Any unspecified impurity | — | 1.00d | 0.5 |
a 17β-Hydroxyestra-4,9,11-trien-3-one.
b (17α )-3-Oxoestra-4,9,11-trien-17-yl acetate.
c (17β)-3-Oxoestra-4,9-dien-17-yl acetate
d Unless determined otherwise.
5 SPECIFIC TESTS
5.1 ABSORBANCE
Sample solution: 100 mg/mL in dehydrated alcohol
Spectrometric conditions
(See Ultraviolet-Visible Spectroscopy (857).)
Analytical wavelength: 440 nm
Cell: 2 cm
Blank: Dehydrated alcohol
Analysis
Samples: Sample solution and Blank
Acceptance criteria: NMT 0.3
5.2 OPTICAL ROTATION, Specific Rotation (7815): +39° to + 43°
Sample solution: 5 mg/mL in methanol
5.3 LOSS ON DRYING (731)
Dry a sample in a vacuum at 60° for 2 h: it loses NMT 0.5% of its weight.
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in tight containers, and store in a refrigerator.
LABELING: Label it to indicate that it is for veterinary use only.
Change to read:
USP REFERENCE STANDARDS (11)
USP Trenbolone Acetate RS
USP Trenbolone Acetate System Suitability Mixture RS
Mixture containing trenbolone and ▲11,12-dihydrotrenbolone acetate ▲(CN 1-Aug-2023) in a matrix of trenbolone acetate.

